These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 1954660)

  • 1. Structural requirements for the inhibition of human monocyte carboxylesterase by organophosphorus compounds.
    Saboori AM; Lang DM; Newcombe DS
    Chem Biol Interact; 1991; 80(3):327-38. PubMed ID: 1954660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human monocyte carboxylesterase. Purification and kinetics.
    Saboori AM; Newcombe DS
    J Biol Chem; 1990 Nov; 265(32):19792-9. PubMed ID: 2246262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of three reputed carboxylesterase inhibitors upon rat serum esterase activity.
    Chambers JP; Hartgraves SL; Murphy MR; Wayner MJ; Kumar N; Valdes JJ
    Neurosci Biobehav Rev; 1991; 15(1):85-8. PubMed ID: 2052204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Organophosphates and monocyte esterase deficiency.
    McClean E; Mackey H; Markey GM; Morris TC
    J Clin Pathol; 1995 Aug; 48(8):768-70. PubMed ID: 7560207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triphenyl phosphite: in vivo and in vitro inhibition of rat neurotoxic esterase.
    Padilla SS; Grizzle TB; Lyerly D
    Toxicol Appl Pharmacol; 1987 Feb; 87(2):249-56. PubMed ID: 3824383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum carboxylesterase activity in various strains of rats: sensitivity to inhibition by CBDP (2-/o-cresyl/4H:1:3:2-benzodioxaphosphorin-2-oxide).
    Clement JG; Erhardt N
    Arch Toxicol; 1990; 64(5):414-6. PubMed ID: 2403290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of carboxylesterase in skin mucus of Cirrhinus mrigala and its assessment as biomarker of organophosphate exposure.
    Nigam AK; Kumari U; Mittal S; Mittal AK
    Fish Physiol Biochem; 2014 Jun; 40(3):635-44. PubMed ID: 24092332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Organophosphate exposure inhibits non-specific esterase staining in human blood monocytes.
    Mandel JS; Berlinger NT; Kay N; Connett J; Reape M
    Am J Ind Med; 1989; 15(2):207-12. PubMed ID: 2471409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The specificity of carboxylesterase protection against the toxicity of organophosphorus compounds.
    Maxwell DM
    Toxicol Appl Pharmacol; 1992 Jun; 114(2):306-12. PubMed ID: 1609424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimation of inhibitory organophosphates with purified pig liver carboxylesterase.
    Heymann E
    Chem Biol Interact; 1999 May; 119-120():577-86. PubMed ID: 10421497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory effects of organophosphate esters on carboxylesterase activity of rat liver microsomes.
    Tsugoshi Y; Watanabe Y; Tanikawa Y; Inoue C; Sugihara K; Kojima H; Kitamura S
    Chem Biol Interact; 2020 Aug; 327():109148. PubMed ID: 32511959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Organophosphorus compound esterase profiles as predictors of therapeutic and toxic effects.
    Makhaeva GF; Radchenko EV; Palyulin VA; Rudakova EV; Aksinenko AY; Sokolov VB; Zefirov NS; Richardson RJ
    Chem Biol Interact; 2013 Mar; 203(1):231-7. PubMed ID: 23123251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative sensitivities of avian neural esterases to in vitro inhibition by organophosphorus compounds.
    Correll L; Ehrich M
    Toxicol Lett; 1987 Apr; 36(2):197-204. PubMed ID: 3576651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A comparative study of the effect of vinyl phosphoric acid esters on cholinesterase and carboxylesterase activities in mammals and arthropods].
    Kugusheva LI; Rozengart VI; Kozenasheva LIa; Kolesova VA
    Zh Evol Biokhim Fiziol; 1990; 26(1):30-4. PubMed ID: 2360379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro deacetylation studies with isomeric acetamidobiphenyls using selective carboxylesterase inhibitors.
    Sertkaya NN; Gorrod JW
    Anticancer Res; 1988; 8(6):1345-50. PubMed ID: 3218967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The inhibition of the high sensitive peripheral nerve soluble esterases by mipafox. A new mathematical processing for the kinetics of inhibition of esterases by organophosphorus compounds.
    Estévez J; García-Pérez AG; Barril J; Pellín M; Vilanova E
    Toxicol Lett; 2004 Jun; 151(1):171-81. PubMed ID: 15177652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The identification and characterization of two separate carboxylesterases in guinea-pig serum.
    Cain K; Reiner E; Williams DG
    Biochem J; 1983 Oct; 215(1):91-9. PubMed ID: 6626182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new selective inhibitor of mouse blood plasma carboxylesterase.
    Rudakova EV; Makhaeva GF; Galenko TG; Aksinenko AY; Sokolov VB; Martynov IV
    Dokl Biochem Biophys; 2013; 449():87-9. PubMed ID: 23657654
    [No Abstract]   [Full Text] [Related]  

  • 19. Purification and characterization of two rat liver microsomal carboxylesterases (hydrolase A and B).
    Morgan EW; Yan B; Greenway D; Petersen DR; Parkinson A
    Arch Biochem Biophys; 1994 Dec; 315(2):495-512. PubMed ID: 7986098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carboxylesterases in primate brain: characterization of multiple forms.
    Chemnitius JM; Zech R
    Int J Biochem; 1983; 15(8):1019-25. PubMed ID: 6617950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.